HGEN - Humanigen Dosing Phase 3 Covid Patients And Other News: The Good Bad And Ugly Of Biopharma
- Humanigen starts dosing patients in Phase 3 COVID-19 vaccine trial.
- AbbVie reports positive topline data for AGN-190584 Phase 3 trial.
- ChemoCentryx reports Phase II AURORA data for Avacopan.
For further details see:
Humanigen Dosing Phase 3 Covid Patients, And Other News: The Good, Bad And Ugly Of Biopharma